In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease

Shu-Tong Huang,1,2,&ast; Jin-Chong Luo,1,3,&ast; Guo-Hui Zhong,1,2 Li-Ping Teng,4 Cai-Yan Yang,4 Chun-Li Tang,1 Lin Jing,1 Zhong-Bo Zhou,4 Jing Liu,1,3 Neng Jiang1,2 1Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People’s Republic of China; 2Pharmaceut...

Full description

Bibliographic Details
Main Authors:	Huang ST, Luo JC, Zhong GH, Teng LP, Yang CY, Tang CL, Jing L, Zhou ZB, Liu J, Jiang N
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-01-01
Series:	Drug Design, Development and Therapy
Subjects:	alzheimer’s disease cholinesterase monoamine oxidase multi-target designed
Online Access:	https://www.dovepress.com/in-vitro-and-in-vivo-biological-evaluation-of-newly-tacrine-selegiline-peer-reviewed-fulltext-article-DDDT

Similar Items

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
by: Zofia Chrienova, et al.
Published: (2022-12-01)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
by: Makoto Naoi, et al.
Published: (2022-09-01)

<i>N</i>-Hydroxy-<i>N</i>-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
by: Óscar M. Bautista-Aguilera, et al.
Published: (2022-11-01)

Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site
by: Rati K. P. Tripathi, et al.
Published: (2018-01-01)

Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase’s and monoamine oxidases: Novel target for the treatment of Alzheimer disease
by: Ejaz Syeda Abida, et al.
Published: (2024-01-01)

(<i>S</i>)-<i>N</i>-Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1<i>H</i>)-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity
by: Qing-Hao Jin, et al.
Published: (2023-02-01)

Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from <i>Glycyrrhiza uralensis</i>
by: Geum Seok Jeong, et al.
Published: (2020-08-01)

Dual Effect of Alternariol on Acetyl Cholinesterase and Monoamineoxidase Extracted from Different Parts of Rat Brain
by: Hassan M.Y. Osman, et al.
Published: (2008-12-01)

Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
by: Tana Tandarić, et al.
Published: (2020-08-01)

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
by: Kok Pin Ng, et al.
Published: (2017-03-01)

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
by: Tapan Behl, et al.
Published: (2021-06-01)

Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education
by: Richard G. Wenzel, et al.
Published: (2010-06-01)

Identification of neurotherapeutic constituents in Ocimum gratissimum with cholinesterase and mono amine oxidase inhibitory activities, using GC-MS analysis, in vitro, and in silico approaches
by: Anoka A. Njan, et al.
Published: (2023-01-01)

Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling
by: Edward E. Putnins, et al.
Published: (2021-11-01)

Nitrogen heterocycles as potential monoamine oxidase inhibitors: Synthetic aspects
by: Pravin O. Patil, et al.
Published: (2014-12-01)

The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01)

Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
by: Rajbir Singh, et al.
Published: (2020-06-01)

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders
by: Priyanka Dhiman, et al.
Published: (2019-01-01)

Recent progress in directed evolution of stereoselective monoamine oxidases
by: Jiaqi Duan, et al.
Published: (2019-09-01)

<i>Annurca</i> Apple Polyphenol Extract Affects Acetyl- Cholinesterase and Mono-Amine Oxidase In Vitro Enzyme Activity
by: Rosarita Nasso, et al.
Published: (2021-01-01)

A twenty-year journey exploring coumarin-based derivatives as bioactive molecules
by: Leonardo Pisani, et al.
Published: (2022-10-01)

Structures and mechanism of the monoamine oxidase family
by: Gaweska Helena, et al.
Published: (2011-10-01)

Colorimetric dopamine detection based on immobilized monoamine oxidase through silver nanoparticles
by: Shin, Gounhanul, et al.
Published: (2023)

SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs
by: Raed Shalaby, et al.
Published: (2019-01-01)

Effects of Natural Monoamine Oxidase Inhibitors on Anxiety-Like Behavior in Zebrafish
by: Oihane Jaka, et al.
Published: (2021-05-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish
by: Diego Baronio, et al.
Published: (2022-03-01)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
by: Wiem Haj Ahmed, et al.
Published: (2020-04-01)

Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents
by: Sheunopa C. Mzezewa, et al.
Published: (2021-01-01)

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
by: Chung-Chieh Hung, et al.
Published: (2024-01-01)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
by: Jong Min Oh, et al.
Published: (2020-05-01)

Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action
by: Mahyar Ostadkarampour, et al.
Published: (2021-04-01)

Synthesis of <i>N</i>′-(4-/3-/2-/Non-substituted benzylidene)-4-[(4-methylphenyl)sulfonyloxy] Benzohydrazides and Evaluation of Their Inhibitory Activities against Monoamine Oxidases and β-Secretase
by: Hasan Erdinç Sellitepe, et al.
Published: (2021-06-01)

Allelic Diversity of VNTR Polymorphism in Monoamine Oxidase A (MAOA) Gene in Young Women and Men in Mashhad, Iran
by: Sedigheh Sadat Hojjati, et al.
Published: (2020-02-01)

Selective Interactions of <i>O</i>-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
by: Narayan D. Chaurasiya, et al.
Published: (2020-11-01)

Assessment of the monoamine oxidase inhibition effect on ischemic preconditioning in isolated rat hearts
by: Andreea Privistirescu, et al.
Published: (2016-12-01)

Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation
by: Alan F. Sved, et al.
Published: (2022-08-01)

Fármacos multifuncionais: monoamina oxidase e α-sinucleína como alvos terapêuticos na doença de Parkinson Multifunctional drugs: monoamine oxidase and α-synuclein as targets for the treatment of Parkinson's disease
by: Cristian Follmer, et al.
Published: (2013-01-01)